Application of Fluid & Imaging Biomarkers to Drug Development in Adult-Onset Leukoencephalopathy
Time: 1:30 pm
day: Conference Day Two
Details:
- Demonstration of proof-of-target engagement and pharmacological activity in early clinical development
- Identification and characterization of biomarkers of disease pathophysiology and/or progression
- Application of such biomarkers to proof-of-concept studies
